TP53 and prostate carcinoma: For instance, it could be shown that GNPs bound to glucose molecules treating prostate cancer cell line DU-145 had a crucial effect on the individual cell’s cell cycle by significantly decreasing tumor protein p53 and arresting cells in radio sensitive G2 phase [51].